Enhancing Tuberculosis Outcomes Through Counselling Incentives

By João L. Carapinha

June 5, 2026

tuberculosis counselling incentives

Tuberculosis counselling incentives that combine conditional cash transfers with structured pre- and post-test counselling are proving highly effective at overcoming socioeconomic barriers to treatment adherence. This integrated strategy reduces long-term disease transmission while requiring only modest additional investment from the health system, making it a practical option for high-burden settings.

By tying financial support to specific health behaviours and pairing it with targeted counselling, tuberculosis counselling incentives directly address the socioeconomic factors that drive loss to follow-up. Patients are more likely to accept treatment, complete their course, and reduce community transmission, delivering meaningful health gains without straining public budgets.

Dynamic Model Projects 25-Year Impact

Using TBMod, an age-structured mathematical model calibrated with results from a pragmatic Johannesburg trial, researchers simulated national rollout from 2025 to 2050. The model accounts for diagnosis pathways, treatment cascades, drug resistance, and transmission dynamics, projecting outcomes against a business-as-usual scenario while remaining consistent with WHO epidemiological targets.

Accelerating Averted Cases and Cost Savings

Impact builds steadily over time. After an initially modest first-year effect, reduced untreated cases curb further spread, leading to a 10.6% drop in new TB cases and 15% fewer deaths by 2050. Across the full period the intervention averts approximately 400,000 incident cases, 200,000 deaths, and 2 million disability-adjusted life years. At an incremental cost of $289 million, the programme costs $80.40 per patient treated and yields an ICER of $144 per DALY averted—well below South Africa’s $3,314 willingness-to-pay threshold. Results remained robust even when counselling and incentive costs were increased by 50%.

Strategic Value for TB Elimination Efforts

These findings, drawn from this economic evaluation, confirm that scaling tuberculosis counselling incentives is an efficient use of public resources. The approach successfully narrows persistent gaps between diagnosis and treatment completion, supporting both national and global TB reduction targets while offering clear lessons for evaluating behavioural interventions in resource-limited settings.

Reference url

Recent Posts

Mirvetuximab ovarian cancer
NICE Guidance on Mirvetuximab Ovarian Cancer Treatment

By HEOR Staff Writer

June 5, 2026

Mirvetuximab ovarian cancer treatment has taken a major step forward after NICE recommended mirvetuximab soravtansine for adults with folate receptor-alpha positive, platinum-resistant high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer who have received one to three...
Immunotherapy for Liver Cancer
Exploring Immunotherapy for Liver Cancer through the EMERALD-3 Trial

By HEOR Staff Writer

June 5, 2026

Immunotherapy for liver cancer has advanced substantially with the EMERALD-3 Phase III trial, which showed that
pharmacy network value
Community Pharmacy Network Value in Enhancing Healthcare Access and Efficiency

By João L. Carapinha

June 3, 2026

A landmark study underscores the pharmacy network value in Portugal, revealing how community pharmacies deliver accessible care, reduce pressure on the National Health Service (SNS), and generate significant economic and environmental returns. With a presence in every municipality, these pharmaci...